Europe
The Company reaffirms that it will file for the lurbinectedin NDA to the FDA under accelerated approval regulations for the treatment of relapsed Small Cell Lung Cancer (SCLC) during the fourth quarter (Q4) of 2019.
Lifebit CloudOS operates as a managed informatics platform that removes the industry barrier of vast amounts of inaccessible distributed omics data, enables federated bioinformatics analysis and machine learning
Recently announced results of open label extension part of SHINE Phase IIb study confirm potential of IFX-1 in Hidradenitis Suppurativa and warrant evaluation of future development
Zelluna Immunotherapy, a biopharma company developing T-cell receptor guided adoptive cell therapy products for treatment of multiple solid cancers, announces it will present data on its lead TCR compound, ZI-H04 at a poster session.
NBE-Therapeutics AG and SOTIO a.s. today announced that SOTIO has elected a second target for the development of a next generation antibody-drug conjugate under their existing license and collaboration agreement.
As part of the European Union’s “Horizon 2020" research program, Evonik and nine project partners from five countries have succeeded in developing a novel new reactor for catalysing OXO reactions, which is 70% more energy efficient.
Asunercept Plus Radiotherapy Significantly Prolongs Time to Deterioration of Quality of Life Compared to Radiotherapy Alone in Patients with Recurrent Glioblastoma
Collaboration aims to evaluate the potential of microbiome-derived antigens that mimic tumor antigens and neoantigens (“onco-mimics”) to induce anti-tumor immune responses
Abcam’s new engineered knockout cell lysates enable proteomic studies by providing researchers with “true negative” controls.
BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, announced that has established a Singapore-based entity in order to spearhead its activities in the Asia Pacific region, including China.
PRESS RELEASES